Bone Morphogenetic Protein 6 (BMP6) Peptide
Quick Overview for Bone Morphogenetic Protein 6 (BMP6) Peptide (ABIN937336)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- DGGSPGRTEQ PPPSPQSSSG FLYRRLKTQE KREMQKEILS VLGLPHRPRP
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of BMP6 antibody,
Alternative Names: BMP6 control peptide, BMP6 antibody Blocking Peptide, Anti-BMP6 Blocking Peptide, bone morphogenetic protein 6 Blocking Peptide, VGR Blocking Peptide, VGR1 Blocking Peptide, BMP6, BMP-6, BMP 6, BMP-6 Blocking Peptide, BMP 6 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- BMP6 (Bone Morphogenetic Protein 6 (BMP6))
-
Background
- The bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that can induce ectopic bone growth. Many BMPs are part of the transforming growth factor-beta (TGFB) superfamily. BMPs were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. Based on its expression early in embryogenesis, the BMP encoded by this gene has a proposed role in early development. In addition, the fact that this BMP is closely related to BMP5 and BMP7 has lead to speculation of possible bone inductive activity.
-
Molecular Weight
- 57 kDa
Target
-